Phase 2 Cholangiocarcinoma Non-resectable Clinical Trials
4 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–4 of 4 trials
Recruiting
Phase 2
Y-90 With Durvalumab/Gem/Cis in Intrahepatic Cholangio
CholangiocarcinomaBile Duct CancerCholangiocarcinoma Non-resectable+2 more
Beth Israel Deaconess Medical Center30 enrolled1 locationNCT05655949
Recruiting
Phase 2
Hepatic Arterial Infusion of Gemcitabine-oxaliplatin for Second-line Therapy in Non-metastatic Unresectable Intra-hepatic Cholangiocarcinoma
Cholangiocarcinoma Non-resectable
University Hospital, Montpellier40 enrolled7 locationsNCT03364530
Recruiting
Phase 2
Combined HAIC, Lenvatinib and Pucotenlimab As Conversion Therapy for Unresectable Intrahepatic Cholangiocarcinoma
Cholangiocarcinoma Non-resectable
Tongji Hospital36 enrolled1 locationNCT06192797
Recruiting
Phase 2
Cadonilimab With Chemotherapy in Treating Advanced Biliary Cancer
Cholangiocarcinoma Non-resectable
West China Hospital65 enrolled1 locationNCT05978609